December 2012 FDA Recall Drug by West-ward Pharmaceutical Corp.
D-133-2013 - Presence of Foreign Substance

This Class II drug recall was voluntarily initiated by West-ward Pharmaceutical Corp. on December 5, 2012 for the product Drug. The FDA reported the reason for recall as presence of foreign substance. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-133-2013

Reason for Recall
Presence of Foreign Substance: A complaint was received for black specks identified as stainless steel inclusions and cellulose with trace amounts of aluminum and iron-rich inclusions.
Initiated
12-05-2012
Reported
01-30-2013
Quantity
60,289 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
West-ward Pharmaceutical Corp.
Nationwide and Puerto Rico
PredniSONE Tablets, USP, 20 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1477-01), b) 500-count tablets per bottle (NDC 0143-1477-05), and c) 1000-count tablets per bottle (NDC 0143-1477-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ 07724.

Batch or Lot Expiration Information

Lot# : 68581A, 68581B, 68382A, 68382B, 68578A, 68578B, 68579A, 68580A, 68582A, 68582B, Exp 01/15